Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
152M
-
Number of holders
-
269
-
Total 13F shares, excl. options
-
35.9M
-
Shares change
-
+139K
-
Total reported value, excl. options
-
$3.7B
-
Value change
-
+$12.7M
-
Number of buys
-
114
-
Number of sells
-
-130
-
Price
-
$102.83
Significant Holders of BIO-TECHNE Corp - COMMON STOCK (TECH) as of Q4 2016
298 filings reported holding TECH - BIO-TECHNE Corp - COMMON STOCK as of Q4 2016.
BIO-TECHNE Corp - COMMON STOCK (TECH) has 269 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35.9M shares
of 152M outstanding shares and own 23.6% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (2.87M shares), Select Equity Group, L.P. (2.33M shares), BROWN CAPITAL MANAGEMENT LLC (2.29M shares), BlackRock Fund Advisors (1.97M shares), Neuberger Berman Group LLC (1.6M shares), BAMCO INC /NY/ (1.6M shares), Mairs & Power INC (1.37M shares), ATLANTA CAPITAL MANAGEMENT CO L L C (1.23M shares), BlackRock Institutional Trust Company, N.A. (1.14M shares), and Jackson Square Partners, LLC (1.05M shares).
This table shows the top 269 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.